Koesten Hirschmann & Crabtree’s iShares Biotechnology ETF IBB Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-72	Closed	-$10.4K	–	120
2025 Q3	$10.4K	Hold	72	–	–	0.01%	140
2025 Q2	$9.11K	Hold	72	–	–	﹤0.01%	151
2025 Q1	$9.21K	Hold	72	–	–	0.01%	135
2024 Q4	$9.52K	Hold	72	–	–	0.01%	129
2024 Q3	$10.5K	Hold	72	–	–	0.01%	121
2024 Q2	$9.88K	Hold	72	–	–	0.01%	134
2024 Q1	$9.88K	Hold	72	–	–	0.01%	134
2023 Q4	$9.78K	Hold	72	–	–	0.01%	118
2023 Q3	$8.8K	Hold	72	–	–	0.01%	108
2023 Q2	$9.14K	Hold	72	–	–	0.01%	101
2023 Q1	$9.3K	Hold	72	–	–	0.01%	112
2022 Q4	$9.45K	Buy	+72	New	+$9.3K	0.01%	105

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Koesten Hirschmann & Crabtree's IBB Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 72 shares — an estimated $10.4K sold.

Koesten Hirschmann & Crabtree first reported a position in IBB in Q4 2022 and held it in 12 quarters. The position peaked at $10.5K in Q3 2024. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Koesten Hirschmann & Crabtree reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Koesten Hirschmann & Crabtree sold 72 iShares Biotechnology ETF shares in Q4 2025, an estimated $10.4K.
Koesten Hirschmann & Crabtree first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 12 quarters.
Koesten Hirschmann & Crabtree's iShares Biotechnology ETF position peaked at $10.5K in Q3 2024.
955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.